Magnus Medical Moves to Protect Intellectual Property Behind Breakthrough SAINT Accelerated Depression Therapy
Magnus Medical Inc., exclusive licensee of a collection of pioneering accelerated neuromodulation patents, today reaffirmed its commitment to protecting the intellectual property behind SAINT® (Stanford Accelerated Intelligent Neuromodulation Therapy) and to protecting patient safety in the rapidly evolving mental health treatment landscape by sending cease-and-desist letters to companies that it believes infringe its patents.
